Brief: Celularity Receives $12.2 Million From Sale Of New Jersey Net Operating Losses
10/02/2026 13:52
Feb 10 (Reuters) - Celularity Inc CELU.O: CELULARITY RECEIVES $12.2 MILLION FROM SALE OF NEW JERSEY NET OPERATING LOSSES Source text: ID:nGNX32CXwk Further company coverage: CELU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celularity
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform
Celularity rises on deal to manufacture MuseCell's cell therapy platform
Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform